Therefore, the PD-L1 antibody targets not only a number of types of immune cells including MDSCs and TAMs to relieve the immunosuppression functions, but also cancer cells that have survived the OV attack yet express PD-L1, which could promote tumour growth (even independent of an immune mechanism)45. Here, CD274 is linked to cancer.